Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Capula Investment Management has hired former AQR trader Yao Hua Ooi to lead a newly formed quantitative commodities trading advisor (CTA) strategy. The Capula Alternative Markets Alpha Fund, which has room for $2 billion to $3 billion in assets, signals the firm's move to broaden its offerings beyond its core relative-value trading business.
Kepler Cheuvreux has started coverage of OHB with a Buy rating and a EUR 260 price target, citing the group's end-to-end space capabilities and its position as a German prime contractor. Management is aiming to grow TOP from EUR 1.2 billion in FY2025 to more than EUR 4 billion in the medium term, implying sales growth above 20% CAGR, while Kepler f…
Comcast (CMCSA) has traded like a legacy media company for most of the last decade. Today it offers a roughly $94B market cap, a >$20B free cash flow stream and a dividend yield near 5% while trading at single-digit earnings multiples and depressed multiples vs. history. With solid cash generation, improving technicals and a valuation that already …
Aprea Therapeutics announced an expansion of its intellectual property portfolio, enhancing protection for its WEE1 kinase inhibitor APR-1051 and ATR inhibitor ATRN-119 programs. The patent estate extends exclusivity into 2045-2047, reinforcing the company's focus on developing targeted therapies for biomarker-defined cancers. This move supports th…
Amarin Corporation presented a new post hoc analysis from the REDUCE-IT cardiovascular outcomes trial at ESC 2026, indicating that patients highly adherent to Icosapent Ethyl (IPE) treatment experienced significant reduction in major adverse cardiovascular events, with benefits lasting years after treatment stopped. This 'legacy effect' underscores…
Ambarella has pivoted from a niche vision-chip provider into a broader edge AI platform play. Strong fiscal 2026 revenue growth, rising share of AI-focused chips, institutional accumulation and recent analyst upgrades create a favorable risk-reward. This trade targets a move back toward the 52-week highs as adoption in surveillance, automotive and …
Meta once again delivered results that reinforce its ad dominance and AI monetization runway. With a $1.45T market cap, 21x earnings and $41B in free cash flow, the setup favors accumulation on pullbacks. We lay out an actionable trade: entry $565.00, stop $525.00, target $700.00 over a 180 trading day horizon.
Nano Labs Ltd, a Nasdaq-listed Web 3.0 infrastructure and crypto treasury company, announced its unaudited financial results for H1 2026, reporting a net loss of RMB316.7 million (US$46.5 million), a sharp decline compared to the same period in 2025. The company attributed losses primarily to decreased cryptocurrency valuations, especially BNB, and…
Rezolve Ai, a US-listed AI-powered commerce technology company, has formed a global strategic alliance with Tech Mahindra, a leading Indian technology consulting firm, to accelerate large-scale deployment of agentic commerce. The partnership leverages Rezolve Ai's Brain Suite AI platform and Tech Mahindra's global consulting and integration capabil…
Minerva Neurosciences, a clinical-stage biopharmaceutical company focused on CNS disorders, announced that its management will participate in two upcoming investor conferences in New York, including the Wells Fargo Healthcare Conference and the 2026 Cantor Global Healthcare Conference. The company will webcast its presentations and provide replay a…
ENvue Medical, Inc., a Nasdaq-listed medical technology company specializing in non-invasive enteral care solutions, announced a 1-for-12 reverse stock split effective September 1, 2026. The reverse split reduces the number of outstanding shares from approximately 11 million to about 924,000, aims to consolidate shares without affecting overall sha…
Callaway (ELY) combines a strong brand, recurring consumables revenue and improving direct-to-consumer channels. Recent weakness has pushed the stock to a valuation that understates cyclical recovery potential. This trade targets a rebound driven by product cadence, margin expansion and modest multiple re-rating.
Core AI Holdings reported strong Q2 2026 financial results with 56% year-over-year revenue growth to $22.4 million and a 97% reduction in gross loss, bringing its gross margin close to breakeven. The improvement was driven by optimized advertising and user acquisition strategies, particularly in its AI-enabled mobile gaming segment. The company als…
AXA looks positioned to outperform over the next 45 trading days as underwriting profits normalize, investment income benefits from higher rates, and the balance sheet remains capital-robust enough to support buybacks and dividends. This trade idea outlines a mid-term long entry with concrete risk controls and clear catalysts to watch.
Mizuho reaffirmed Welltower Inc. as its leading REIT selection and retained an Outperform rating on Ventas Inc., citing strong adjusted funds from operations (AFFO) growth forecasts and encouraging second-quarter revenue results. The firm set price targets implying roughly 8% upside for Welltower and 11% for Ventas, while highlighting valuation dif…
European natural gas benchmarks retreated from session highs on Friday after a multi-session rally, yet remained on course to record a third straight weekly gain. Traders pared some of the geopolitical risk premium after reports that regional mediators had opened talks to protect commercial transit through the Strait of Hormuz, but physical market …
Hecate Energy and EGH Acquisition Corp. announced the resolution of lender and litigation matters, enabling progress toward Hecate's planned Nasdaq listing under ticker 'HCTE' via a business combination with EGH. The transaction, valuing Hecate at $1.2 billion pre-money, is expected to close in Q1 2027, providing capital to develop and monetize Hec…
Mobia Medical announces that implantable paired Vagus Nerve Stimulation (VNS) has been recognized in the 2026 American Heart Association (AHA) stroke rehabilitation guidelines as a treatment option to improve upper-limb function in chronic stroke survivors. Their FDA-approved Vivistim® Paired VNS System is the only device delivering this therapy. T…
Alnylam Pharmaceuticals stock fell about 6% after AstraZeneca announced that a Phase 3 trial of its experimental silencer therapy for ATTR-CM failed. The study found no benefit for patients who were already taking a stabilizer drug, and most participants were on such therapy at enrollment. The outcome casts uncertainty over the silencer drug approa…
Elastic reported accelerating revenue and cloud adoption that undercuts the narrative of a broad SaaS slowdown. Q1 FY2026 results showed revenue of $478.11M (+15.1% YoY) with Elastic Cloud up 20.1%. Valuation sits at a midteens earnings multiple and EV/Sales near 4.9, leaving room for upside if cloud traction and margins continue to improve. This i…
Marvell Technology reported upbeat revenue forecasts for fiscal 2027 and 2028 but saw its shares fall sharply in premarket trading after investors expressed concerns about when the company will realize the potential upside from a large custom-chip agreement with Alphabet’s Google. Management said some Google-related revenue is already included in n…
XORTX Therapeutics Inc. has terminated its investor relations agreement with IR Agency LLC and returned the previously paid marketing fees, opting to postpone its investor relations program while completing its voluntary delisting from the TSX Venture Exchange. The company aims to reduce regulatory complexity and focus on advancing its pharmaceutic…
iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotech company, announced its FY 2026 financial results and highlighted significant advancements including the initiation of Phase 1 clinical trials for IBIO-600 and IND-enabling studies for IBIO-610 and IBIO-800. The company strengthened its leadership, secured substantial financing extending its cash r…
Chagee Holdings Limited announced its Q2 2026 unaudited financial results, showing a 2.5% increase in net revenues to RMB3.41 billion and a substantial 387.6% rise in operating income to RMB524.7 million. Despite revenue growth, same store GMV declined 16.1% in Greater China due to economic headwinds and intense competition. The company's teahouse …
MoneyHero Limited, a Nasdaq-listed fintech company specializing in AI-powered personal finance aggregation and digital insurance brokerage in Greater Southeast Asia, announced it will release its Q2 2026 results on September 11, 2026, before market open and host a conference call. The firm operates across Singapore, Hong Kong, Taiwan, and the Phili…
